HER2 positive breast cancer HER2
effective treatment of HER2
HER2 endosomal traffic
effective cancer treatment
type of cancer
breast cancer patients
cancer models
aggressive type of breast cancer
breast cancers
functional HER2 oncogenic signalling
therapeutic targeting of endosomal traffic
therapeutic avenue
effective clinical results
current therapeutic antibodies
proper endosomal trafficking
risk of therapy resistance
current treatments
ERC-PoC
ERC-CoG project
monotherapy
plasma membrane
inhibition of sorting proteins
market
poor prognosis
commercial avenues
finding
therapies
innovation